MarketWatch

The bear case on Eli Lilly has played out, says only firm to have called it a sell

The bear case for Eli Lilly has now played out following the market reaction to the drug manufacturer’s oral obesity drug trial, an analyst said Wednesday in upgrading the stock. HSBC analysts led by ...
Óstáilte ar MSN

Market delayed in reaction to Novo Nordisk and Eli Lilly' s GLP-1 pills, says Mizuho's Jared Holz

Jared Holz, Mizuho, joins 'Fast Money' to talk competition in the GLP-1 pill space between Novo Nordisk and Eli Lilly. Donald Trump suffers double legal blow within hours Scientists Discovered A New ...